Bio-Techne (TECH) Insider Trading & Ownership $74.26 +0.52 (+0.71%) (As of 10/9/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Bio-Techne (NASDAQ:TECH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.45%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$800,592.00 Get TECH Insider Trade Alerts Want to know when executives and insiders are buying or selling Bio-Techne stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TECH Insider Buying and Selling by Quarter Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And this fear has caused the entire crypto market to plunge. But everyone is forgetting one thing…Bitcoin was created in the aftermath of the 2008 financial crisis. Click here to reserve your spot at the emergency crypto summit now. Bio-Techne Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2024Roeland NusseDirectorSell10,400$76.98$800,592.00 (Data available from 1/1/2013 forward) TECH Insider Trading Activity - Frequently Asked Questions Who is on Bio-Techne's Insider Roster? The list of insiders at Bio-Techne includes Brenda S Furlow, Charles R Kummeth, James Hippel, John L Higgins, Kim Kelderman, Norman David Eansor, Robert V Baumgartner, and Roeland Nusse. Learn more on insiders at TECH. What percentage of Bio-Techne stock is owned by insiders? 4.45% of Bio-Techne stock is owned by insiders. Learn more on TECH's insider holdings. Which Bio-Techne insiders have been selling company stock? The following insiders have sold TECH shares in the last 24 months: Brenda S Furlow ($65,608.00), Charles R Kummeth ($7,068,800.00), and Roeland Nusse ($1,518,572.48). How much insider selling is happening at Bio-Techne? Insiders have sold a total of 100,139 Bio-Techne shares in the last 24 months for a total of $8,652,980.48 sold. Bio-Techne Key ExecutivesMr. Kim Kelderman (Age 56)CEO, President & Director Compensation: $845.71kMr. James T. Hippel (Age 53)Executive VP of Finance & CFO Compensation: $691.78kMr. Shane Bohnen (Age 49)Senior VP, General Counsel & Corporate Secretary Compensation: $353.6kMr. Charles R. Kummeth (Age 64)Senior Advisor & Director Compensation: $1.26MMr. William A. Geist (Age 54)President of Protein Sciences Segment Compensation: $533.67kDr. Gary J. Latham Ph.D.VP & CTODavid ClairSenior Director of Investor Relations & Corporate DevelopmentMr. Gerry AndrosVice President of Sales and MarketingMr. Robert M. Gavin (Age 56)Vice President of Corporate Development Compensation: $724.51kMr. Luca CicchettiManaging Director More Insider Trading Tools from MarketBeat Related Companies: Agilent Technologies Insider Ownership Mettler-Toledo International Insider Ownership Waters Insider Ownership Illumina Insider Ownership Charles River Laboratories International Insider Ownership Bruker Insider Ownership Bio-Rad Laboratories Insider Ownership Pacific Biosciences of California Insider Ownership Harvard Bioscience Insider Ownership Thermo Fisher Scientific Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now This page (NASDAQ:TECH) was last updated on 10/10/2024 by MarketBeat.com Staff From Our PartnersBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredAI Expert Reveals New PickWhy You Shouldn't Pour All Your Money Into Nvidia Jeff Brown, who predicted Nvidia's rise, warns against pu...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
